Engelson Erik T. - 03 Mar 2023 Form 4 Insider Report for Lucira Health, Inc.

Role: President and Chief Executive, Director
Signature: /s/ Erik Engelson
Issuer symbol: N/A
Transactions as of: 03 Mar 2023
Net transactions value: -$186,080
Form type: 4
Filing time: 13 Mar 2023, 18:30:09 UTC
Previous filing: 19 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LHDXQ	Common Stock	Options Exercise	$471,226	+574,666	+690%	$0.8200^*	657,948	03 Mar 2023	Direct
transaction	LHDXQ	Common Stock	Sale	$591,906	-574,666	-87%	$1.03^*	83,282	03 Mar 2023	Direct
transaction	LHDXQ	Common Stock	Sale	$65,400	-60,000	-72%	$1.09^*	23,282	03 Mar 2023	Direct
holding	LHDXQ	Common Stock						46,400	03 Mar 2023	See Footnotes	F1
holding	LHDXQ	Common Stock						191,705	03 Mar 2023	See Footnotes	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LHDXQ	Common Stock	Options Exercise	$0	-574,666	-100%	$0.000000^*	0	03 Mar 2023	Common Stock	574,666	$0.8200	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
F2	The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3	The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.